8i Acquisition 2 Corp.
Status: Closed Deal
U=S+W+R
W=S/2@$11.50
R=S/10
| IPO Proceeds, $M | $86.25M |
|---|---|
| IPO Date | Nov 22, 2021 |
| CEO | Meng Dong (James) Tan |
| Left Lead | Maxim |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 12 + (2*3) |
| IPO Sector | General ▶ |
| IPO Geography | Asia |
| Target Company | EUDA Health |
| Deal Announced | Apr 12, 2022 |
| Deal Size, $M | $262.00M |
| Deal Sector | Healthcare |
| Deal Geography | Asia |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Nov 10, 2022 |
| Amendment Vote | TBD |
| Closing Date | Nov 17, 2022 |
Formerly LAX
EUDA
EUDAW
| Price | $2.05 |
|---|---|
| Last closing price | $2.09 |
| H/L, today | $1.90 / $2.16 |
| H/L, 52-week | $0.43 / $6.34 |
| Volume, today | 63,965 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.